new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Amgen Research munich Gmbh patents

Recent patent applications related to Amgen Research munich Gmbh. Amgen Research munich Gmbh is listed as an Agent/Assignee. Note: Amgen Research munich Gmbh may have other listings under different names/spellings. We're not affiliated with Amgen Research munich Gmbh, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amgen Research munich Gmbh-related inventors




Date Amgen Research munich Gmbh patents (updated weekly) - BOOKMARK this page
02/09/17Antibody constructs for dll3 and cd3
02/09/17Immune-checkpoint inhibitors for use in the treatment of blood-borne cancers
02/09/17Antibody constructs for flt3 and cd3
02/02/17Antibody constructs for msln and cd3
11/03/16Combination of epigenetic factors and bispecific compounds targeting cd33 and cd3 in the treatment of myeloid leukemia
09/15/16Bispecific single chain antibodies with specificity for high molecular weight target antigens
07/21/16Means and methods for treating dlbcl
06/23/16Binding molecules for bcma and cd3
06/02/16Cross-species-specific bispecific binders
05/12/16Antibody neutralizers of human granulocyte macrophage colony stimulating factor
05/05/16Single chain binding molecules comprising n-terminal abp
02/11/16Antibody constructs for influenza m2 and cd3
02/04/16Antibody constructs for cdh19 and cd3
12/24/15Antibody constructs for cdh19 and cd3
12/03/15Lyophilized formulation comprising gm-csf neutralizing compound
11/05/15Liquid formulation comprising gm-csf neutralizing compound
03/12/15Dosage regimen for administering a cd19xcd3 bispecific antibody
02/05/15Long life polypeptide binding molecules
01/22/15Binding molecules for bcma and cd3
10/30/14Antibody constructs for cdh19 and cd3
08/14/14Anti-leukocyte adhesion for the mitigation of potential adverse events caused by cd3-specific binding domains
08/14/14Pps for the prevention of potential adverse effects caused by cd3 specific binding domains
07/17/14Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
10/31/13Prevention of adverse effects caused by cd3 specific binding domains
10/31/13Means and methods for treating dlbcl
07/11/13Treatment of metastatic breast cancer
07/04/13Preparation of scfv antibody fragments
06/20/13Binding molecules for bcma and cd3
06/20/13Binding molecules for bcma and cd3
05/23/13Compositions comprising cross-species-specific antibodies and uses thereof
05/23/13Cross-species-specific psmaxcd3 bispecific single chain antibody







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amgen Research munich Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amgen Research munich Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';